Telormedix SA
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Private
- Established
- 2007-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.telormedix.com
Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer
Phase 2
Completed
- Conditions
- Carcinoma in SituNon Muscle Invasive Bladder Cancer
- Interventions
- First Posted Date
- 2012-11-22
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- Telormedix SA
- Target Recruit Count
- 12
- Registration Number
- NCT01731652
- Locations
- 🇺🇸
Urologic Consultants of SE PA, Bala Cynwyd, Pennsylvania, United States
🇺🇸The Urology Center of Colorado, Denver, Colorado, United States
🇺🇸BCG Oncology, Phoenix, Arizona, United States
© Copyright 2025. All Rights Reserved by MedPath